Elite in Patent Ductus Arteriosus

Mikko K. Hallman

Oulu, FI 
Clinical Trials:Currently Recruiting for 1 Trial
Elite in Patent Ductus Arteriosus
Oulu, FI 
OverviewLocationsClinical Research

Overview

Mikko Hallman practices in Oulu, Finland. Hallman is rated as an Elite expert by MediFind in the treatment of Patent Ductus Arteriosus. Their top areas of expertise are Patent Ductus Arteriosus, Premature Infant, Bronchopulmonary Dysplasia, and Infant Respiratory Distress Syndrome.

Their clinical research consists of co-authoring 143 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 18 articles and participated in 3 clinical trials in the study of Patent Ductus Arteriosus.

Locations

Oulu, Finland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 Compared to Standard Neonatal Care for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease of Prematurity
A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 Compared to Standard Neonatal Care for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease of Prematurity
Enrollment Status: Recruiting
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drug: SHP607
Study Phase: Phase 2
The Preterm Infants' Paracetamol Study
The Preterm Infants' Paracetamol Study
Enrollment Status: Completed
Publish Date: October 18, 2024
Intervention Type: Drug
Study Drug: Paracetamol
Study Phase: Phase 2
Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus of Preterm Infants - Randomised, Placebo-controlled Multicentre Trial
Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus of Preterm Infants - Randomised, Placebo-controlled Multicentre Trial
Enrollment Status: Terminated
Publish Date: October 18, 2024
Intervention Type: Drug
Study Drugs: Paracetamol, Ibuprofen, Indomethacin
Study Phase: Phase 1
Extremely Low Gestational Age Infants' Paracetamol Study: a Randomized Trial
Extremely Low Gestational Age Infants' Paracetamol Study: a Randomized Trial
Enrollment Status: Completed
Publish Date: March 15, 2024
Intervention Type: Drug, Other
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

141 Total Publications

Paracetamol Concentrations and Time-Course of Ductus Arteriosus Diameter in Extremely Preterm Neonates: A Population Pharmacokinetic-Pharmacodynamic Analysis.
Paracetamol Concentrations and Time-Course of Ductus Arteriosus Diameter in Extremely Preterm Neonates: A Population Pharmacokinetic-Pharmacodynamic Analysis.
Journal: Clinical pharmacokinetics
Published: March 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hallman's expertise for a condition
ConditionClose
View All 13 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile